loading

Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
36.81%
1.3578
2.1487 1.7299 1.51 1.5814
Depreciation and Amortization
0.024
- - - -
Operating Income/Loss
18.39%
-3.1101
-3.8109 -3.6802 -3.2596 -3.0046
Nonoperating Income/Loss
23.33%
0.0726
0.0947 0.1169 0.0819 0.00477
Income/Loss From Continuing Operations Before Tax
18.26%
-3.0374
-3.7162 -3.5632 -3.1777 -2.9998
Income/Loss From Continuing Operations After Tax
18.26%
-3.0374
-3.7162 -3.5632 -3.1777 -2.9998
Net Income/Loss
18.26%
-3.0374
-3.7162 -3.5632 -3.1777 -2.9998
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
31.95%
7.4436
5.6413 2.2112 0.0528 1.0441
Diluted Average Shares
31.95%
7.4436
5.6413 2.2112 0.0528 1.0441
Basic Earnings Per Share
37.88%
-0.41
-0.66 -1.61 - -
Diluted Earnings Per Share
37.88%
-0.41
-0.66 -1.61 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):